CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-25 | Anzalone Christopher Richard Chief Executive Officer | Sale | −20,000 | $28.25 | $565K | 2,121,903 |
| 2019-09-24 | Anzalone Christopher Richard Chief Executive Officer | Option exercise | +66,645 | $5.10 | $340K | 2,208,548 |
| 2019-09-24 | Anzalone Christopher Richard Chief Executive Officer | Sale | −53,972 | $28.00 | $1.5M | 2,154,576 |
| 2019-09-24 | Anzalone Christopher Richard Chief Executive Officer | Sale | −12,673 | $29.04 | $368K | 2,141,903 |
| 2019-09-24 | Anzalone Christopher Richard Chief Executive Officer | Option exercise · Stock Option (right to buy) | −66,645 | 1,001,868 | ||
| 2019-09-23 | Anzalone Christopher Richard Chief Executive Officer | Option exercise | +41,755 | $5.10 | $213K | 2,183,658 |
| 2019-09-23 | Anzalone Christopher Richard Chief Executive Officer | Sale | −41,755 | $29.04 | $1.2M | 2,141,903 |
| 2019-09-23 | Anzalone Christopher Richard Chief Executive Officer | Option exercise · Stock Option (right to buy) | −41,755 | 1,068,513 | ||
| 2019-09-20 | Anzalone Christopher Richard Chief Executive Officer | Option exercise | +4,250 | $5.10 | $22K | 2,146,153 |
| 2019-09-20 | Anzalone Christopher Richard Chief Executive Officer | Sale | −4,250 | $29.00 | $123K | 2,141,903 |
| 2019-09-20 | Anzalone Christopher Richard Chief Executive Officer | Option exercise · Stock Option (right to buy) | −4,250 | 1,110,268 | ||
| 2019-09-11 | PERRY MICHAEL S Director | Sale | −85,000 | $30.00 | $2.5M | 36,000 |
| 2019-09-09 | PERRY MICHAEL S Director | Sale | −100,000 | $28.90 | $2.9M | 121,000 |
| 2019-06-26 | Ferrari Mauro Director | Sale | −17,756 | $27.61 | $490K | 1,900 |
| 2019-05-31 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +15,000 | $4.60 | $69K | 293,536 |
| 2019-05-31 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +20,000 | $5.19 | $104K | 313,536 |
| 2019-05-31 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −15,000 | 220,000 | ||
| 2019-05-31 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −20,000 | 200,000 | ||
| 2019-05-28 | O'Brien Patrick General Counsel | Sale | −30,000 | $24.88 | $746K | 203,000 |
| 2019-05-24 | Anzalone Christopher Richard Chief Executive Officer | Option exercise | +40,072 | $2.01 | $81K | 2,132,527 |
Page 29 of 38 · 752 trades